PET/MRI

NYU Langone Opens New Imaging Center

NYU Langone Health has opened a 28,000-square-foot imaging center on Manhattan's Upper West Side, offering PET/MR, cardiac CT and 3D mammography.

PSMA PET/CT improves prostate cancer detection

A prospective study found PSMA PET/CT-targeted biopsy detected more clinically significant prostate cancer than systematic biopsy in men with nondiagnostic MRI.

Midea Completes Acquisition of Esaote

Midea Group has expanded its presence in the medical technology sector with the acquisition of a controlling stake in Italian medical imaging company Esaote, bringing the company into its Healthcare Division.

Miniaturized Platform for PET Radiotracer Production

USC researchers are developing a miniaturized PET radiotracer platform designed to simplify production, accelerate tracer development and expand molecular imaging applications.

Bayer Reports Phase III PET Radiotracer Results in Cardiac Amyloidosis

Bayer reports Phase III results for investigational I 124 evuzamitide in cardiac amyloidosis, with primary endpoints met for visual PET scan interpretation.

FAP-targeted PET/MRI Shows Higher Endometriosis Detection in Difficult-to-assess Areas

A retrospective study found FAP-targeted PET/MRI identified more endometriosis-suspicious findings than MRI alone, including difficult-to-assess areas.

Catalyst MedTech Expands Brain PET Implementation in the U.S.

The solution is designed to enable healthcare providers to implement molecular imaging workflows without traditional infrastructure barriers.

Bayer Expands Radiology Portfolio Into Diagnostic Tracers

Acquisition of AT-01 and AT-05 expands Bayer’s molecular imaging portfolio.

RSNA 2025: Imaging the Hidden Language of the Brain

A session highlighting how amyloid, tau, and FDG PET sharpen Alzheimer’s diagnosis, support therapy decisions, and improve safety monitoring, marking a key advance in precision imaging.